Table of Contents

2019-2024 Global Biopharmaceuticals Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Biopharmaceuticals Consumption 2014-2024
  • 2.1.2 Biopharmaceuticals Consumption CAGR by Region
• 2.2 Biopharmaceuticals Segment by Type
  • 2.2.1 Monoclonal Antibodies
  • 2.2.2 Interferon
  • 2.2.3 Colony-Stimulating Factor
  • 2.2.4 Erythropoietin
  • 2.2.5 Insulin
  • 2.2.6 Vaccines
  • 2.2.7 Growth Hormones
  • 2.2.8 Others
• 2.3 Biopharmaceuticals Consumption by Type
  • 2.3.1 Global Biopharmaceuticals Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Biopharmaceuticals Sale Price by Type (2014-2019)
• 2.4 Biopharmaceuticals Segment by Application
  • 2.4.1 Tumor
  • 2.4.2 Diabetes
  • 2.4.3 Cardiovascular
  • 2.4.4 Hemophilia
  • 2.4.5 Others
• 2.5 Biopharmaceuticals Consumption by Application
  • 2.5.1 Global Biopharmaceuticals Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Biopharmaceuticals Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Biopharmaceuticals Sale Price by Application (2014-2019)

3 Global Biopharmaceuticals by Players

• 3.1 Global Biopharmaceuticals Sales Market Share by Players
  • 3.1.1 Global Biopharmaceuticals Sales by Players (2017-2019)
  • 3.1.2 Global Biopharmaceuticals Sales Market Share by Players (2017-2019)
• 3.2 Global Biopharmaceuticals Revenue Market Share by Players
  • 3.2.1 Global Biopharmaceuticals Revenue by Players (2017-2019)
  • 3.2.2 Global Biopharmaceuticals Revenue Market Share by Players (2017-2019)
• 3.3 Global Biopharmaceuticals Sale Price by Players
• 3.4 Global Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Biopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Biopharmaceuticals Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Biopharmaceuticals by Regions

• 4.1 Biopharmaceuticals by Regions
  • 4.1.1 Global Biopharmaceuticals Consumption by Regions
  • 4.1.2 Global Biopharmaceuticals Value by Regions
• 4.2 Americas Biopharmaceuticals Consumption Growth
• 4.3 APAC Biopharmaceuticals Consumption Growth
• 4.4 Europe Biopharmaceuticals Consumption Growth
• 4.5 Middle East & Africa Biopharmaceuticals Consumption Growth

5 Americas

• 5.1 Americas Biopharmaceuticals Consumption by Countries
  • 5.1.1 Americas Biopharmaceuticals Consumption by Countries (2014-2019)
  • 5.1.2 Americas Biopharmaceuticals Value by Countries (2014-2019)
• 5.2 Americas Biopharmaceuticals Consumption by Type
• 5.3 Americas Biopharmaceuticals Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Biopharmaceuticals Consumption by Countries
  • 6.1.1 APAC Biopharmaceuticals Consumption by Countries (2014-2019)
  • 6.1.2 APAC Biopharmaceuticals Value by Countries (2014-2019)
• 6.2 APAC Biopharmaceuticals Consumption by Type
• 6.3 APAC Biopharmaceuticals Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Biopharmaceuticals by Countries
  • 7.1.1 Europe Biopharmaceuticals Consumption by Countries (2014-2019)
  • 7.1.2 Europe Biopharmaceuticals Value by Countries (2014-2019)
• 7.2 Europe Biopharmaceuticals Consumption by Type
• 7.3 Europe Biopharmaceuticals Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Biopharmaceuticals by Countries
  • 8.1.1 Middle East & Africa Biopharmaceuticals Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Biopharmaceuticals Value by Countries (2014-2019)
• 8.2 Middle East & Africa Biopharmaceuticals Consumption by Type
• 8.3 Middle East & Africa Biopharmaceuticals Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Biopharmaceuticals Distributors
• 10.3 Biopharmaceuticals Customer

11 Global Biopharmaceuticals Market Forecast

• 11.1 Global Biopharmaceuticals Consumption Forecast (2019-2024)
• 11.2 Global Biopharmaceuticals Forecast by Regions
  • 11.2.1 Global Biopharmaceuticals Forecast by Regions (2019-2024)
  • 11.2.2 Global Biopharmaceuticals Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Biopharmaceuticals Forecast by Type
• 11.8 Global Biopharmaceuticals Forecast by Application

12 Key Players Analysis

• 12.1 Roche
  • 12.1.1 Company Details
  • 12.1.2 Biopharmaceuticals Product Offered
  • 12.1.3 Roche Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Roche News
• 12.2 Amgen
  • 12.2.1 Company Details
  • 12.2.2 Biopharmaceuticals Product Offered
  • 12.2.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Amgen News
• 12.3 AbbVie
  • 12.3.1 Company Details
  • 12.3.2 Biopharmaceuticals Product Offered
  • 12.3.3 AbbVie Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 AbbVie News
• 12.4 Sanofi-Aventis
  • 12.4.1 Company Details
  • 12.4.2 Biopharmaceuticals Product Offered
  • 12.4.3 Sanofi-Aventis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sanofi-Aventis News
• 12.5 Johnson & Johnson
  • 12.5.1 Company Details
  • 12.5.2 Biopharmaceuticals Product Offered
  • 12.5.3 Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Johnson & Johnson News
• 12.6 Pfizer
  • 12.6.1 Company Details
  • 12.6.2 Biopharmaceuticals Product Offered
  • 12.6.3 Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Pfizer News
• 12.7 Novo Nordisk
  • 12.7.1 Company Details
  • 12.7.2 Biopharmaceuticals Product Offered
  • 12.7.3 Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Novo Nordisk News
• 12.8 Eli Lilly
  • 12.8.1 Company Details
  • 12.8.2 Biopharmaceuticals Product Offered
  • 12.8.3 Eli Lilly Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Eli Lilly News
• 12.9 Novartis
  • 12.9.1 Company Details
  • 12.9.2 Biopharmaceuticals Product Offered
  • 12.9.3 Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Novartis News
• 12.10 Merck
  • 12.10.1 Company Details
  • 12.10.2 Biopharmaceuticals Product Offered
  • 12.10.3 Merck Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Merck News

13 Research Findings and Conclusion

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated
With manufacturing (if the trials are successful).
An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).

According to this study, over the next five years the Biopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study considers the Biopharmaceuticals value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tumor
Diabetes
Cardiovascular
Hemophilia
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Biopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Biopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.